11:44 AM EST - Concordia Healthcare Corp. : announced it has entered into a definitive asset purchase agreement to acquire substantially all of the commercial assets of privately held Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l for $1.2 billion U.S. in cash. Concordia Healthcare Corp.
shares T.CXR are trading up $14.53 at $78.69.
